Bayer Cleared for U.S. Spinal Test
Wed Nov 20, 8:21 AM ET Add Health - AP to My Yahoo!



FRANKFURT, Germany (AP) - Germany's Bayer AG said Wednesday it had received U.S. government permission to market an automated spinal fluid diagnostic test the company says is faster and more precise than manual tests.

Related Quotes
BAY
DJIA
NASDAQ
^SPC
23.13
8623.01
1416.36
913.33
-0.21
+148.23
+41.85
+16.59



delayed 20 mins - disclaimer
Quote Data provided by Reuters



The test can be run on an existing machine used to analyze blood samples, the company said, and takes only five minutes as opposed to 30-45 minutes for manual testing, in which a lab worker examines a sample under a microscope.


The company said the automated test reduces the chance for error caused by mishandling of samples.


The test is made by Bayer HealthCare Diagnostics, a subsidiary of Leverkusen-based Bayer. The diagnostics subsidiary is located in Tarrytown, N.Y.


Tests of cerebrospinal fluid - the fluid surrounding the brain and spinal cord - are used to evaluate diseases such as meningitis, encephalitis, bleeding into the brain and some forms of leukemia.